Living with type 1 diabetes ain’t necessarily mean bidding sports adieu. Right sports medicine coupled with an optimal exercise plan lets diabetics partake in physical activities. Learning the balance game between insulin, nutrition intake, workouts, and blood sugar control is of utmost concern for maintaining steady sugar levels during sports. In this blog post, we…
Type 1 diabetes (t1d) is a chronic condition that occurs when the body’s immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas. Managing type 1 diabetes requires a vigilant and comprehensive approach to maintain blood glucose levels within a target range, prevent complications, and enhance overall well-being. Here’s a comprehensive guide for…
Previously Published on Endocrinologyadvisor.com – Findings from a 17-week, randomized, open-label, crossover study comparing the efficacy of fast-acting insulin aspart (faster aspart) with standard insulin aspart (IAsp) delivered by an automated closed-loop system in adults with type 1 diabetes(T1D) showed faster aspart demonstrated greater glucose time in range (TIR) compared with IAsp (82.3% [78.5, 83.7]…
Previously published on Diabetestimes.co.uk – People with type 1 diabetes can benefit from a ketogenic lifestyle just as much as those without the condition. This new study was reported in the journal Endocrinology, Diabetes and Obesity. The feasibility of exercising over five days while fasting, in those with and without t1d mellitus, tested during the study. Academic, Ian Lake, analyzed…
Previously Published on Biospace.com – Neximmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced a collaboration with Yale University’s Department of Immunobiology. The collaboration will focus on the use of NexImmune’s direct injection, artificial antigen…
Previously Published on Healio.com – ADO09, a co-formulation of pramlintide and insulin A21G, was associated with better glucose levels, improved time in range and more weight loss among people with type 1 diabetes compared with insulin aspart, according to a presenter. “ADO09 is a new and innovative co-formulation of two hormones missing in type 1 diabetes: insulin…
Previously Published on Medical News Today – New research uses stem cells and a tiny device, the implant reverses type 1 diabetes in mice. Insulin-secreting beta cells can reverse type 1 diabetes in mice. Introducing these cells without triggering the immune system has been a critical challenge. Researchers have developed an apparently safe, functional device for delivery…
Previously Published on WebMD – MONDAY, March 8, 2021 (HealthDay News) — Just two weeks of treatment with an experimental drug can delay the onset of type 1 diabetes by several years, researchers report. The drug, called teplizumab, is already under review by the U.S. Food and Drug Administration based on earlier evidence of its effectiveness….
Two most common types of diabetes are type 1 and type 2. Type 1 diabetes, aka insulin-dependent diabetes, is a disease of the lean and young. A majority of type 1 diabetes diagnoses occur before the end of adolescence. This means that it has to be managed lifelong with the correct information of type 1…